Clinical Trial Update: Patients With Relapsed or Refractory Diffuse Large B Cell Non Hodgkin Lymphomas [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update for relapsed or refractory diffuse large B-cell non-Hodgkin lymphoma that has been terminated with results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Non-hodgkin Lymphoma

Snippet

Sponsor: Oncology Specialists, S.C. | Conditions: Non-Hodgkin Lymphomas | Phase 2 | Status: TERMINATED | Results posted: 2014-05-02